Trimedyne, Inc. reported financial results for the first quarter ended December 31, 2012. Revenues for the quarter ended December 31, 2012, were $1,475,000, a 6% increase from revenues of $1,390,000 for the same quarter of the prior year. The company had a net loss of $144,000 or $0.01 per share for the current quarter, compared to a loss of $285,000 or $0.02 per share for the same quarter of the prior year.
1st Jan change | Capi. | |
---|---|---|
+4.85% | 212B | |
+9.86% | 188B | |
+31.11% | 157B | |
+34.08% | 114B | |
+2.97% | 64.01B | |
+1.63% | 48.83B | |
-3.12% | 39.3B | |
+1.93% | 35.97B | |
+6.87% | 27B |